Product NDC: | 11994-012 |
Proprietary Name: | Ablavar |
Non Proprietary Name: | Gadofosveset trisodium |
Active Ingredient(s): | 244 mg/mL & nbsp; Gadofosveset trisodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11994-012 |
Labeler Name: | Lantheus Medical Imaging, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021711 |
Marketing Category: | NDA |
Start Marketing Date: | 20081212 |
Package NDC: | 11994-012-02 |
Package Description: | 10 VIAL in 1 BOX (11994-012-02) > 15 mL in 1 VIAL |
NDC Code | 11994-012-02 |
Proprietary Name | Ablavar |
Package Description | 10 VIAL in 1 BOX (11994-012-02) > 15 mL in 1 VIAL |
Product NDC | 11994-012 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Gadofosveset trisodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20081212 |
Marketing Category Name | NDA |
Labeler Name | Lantheus Medical Imaging, Inc. |
Substance Name | GADOFOSVESET TRISODIUM |
Strength Number | 244 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |